Cargando…
The use of long non-coding RNAs as prognostic biomarkers and therapeutic targets in prostate cancer
Prostate cancer is the most common cancer in men and the second leading cause of cancer-related deaths. The most used biomarker to detect prostate cancer is Prostate Specific Antigen (PSA), whose levels are measured in serum. However, it has been recently established that molecular markers of cancer...
Autores principales: | Arriaga-Canon, Cristian, De La Rosa-Velázquez, Inti Alberto, González-Barrios, Rodrigo, Montiel-Manríquez, Rogelio, Oliva-Rico, Diego, Jiménez-Trejo, Francisco, Cortés-González, Carlo, Herrera, Luis A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5945524/ https://www.ncbi.nlm.nih.gov/pubmed/29755696 http://dx.doi.org/10.18632/oncotarget.25038 |
Ejemplares similares
-
The promising role of new molecular biomarkers in prostate cancer: from coding and non-coding genes to artificial intelligence approaches
por: Alarcón-Zendejas, Ana Paula, et al.
Publicado: (2022) -
The Promising Role of miR-21 as a Cancer Biomarker and Its Importance in RNA-Based Therapeutics
por: Bautista-Sánchez, Diana, et al.
Publicado: (2020) -
Transcriptomics and RNA-Based Therapeutics as Potential Approaches to Manage SARS-CoV-2 Infection
por: Arriaga-Canon, Cristian, et al.
Publicado: (2022) -
Epidrug Repurposing: Discovering New Faces of Old Acquaintances in Cancer Therapy
por: Montalvo-Casimiro, Michel, et al.
Publicado: (2020) -
Insights of Oncofertility in Mexico and Latin America
por: Jiménez-Trejo, Francisco, et al.
Publicado: (2022)